Status:
COMPLETED
Combined Treatment of Nightmares With Targeted Memory Reactivation and Imagery Rehearsal Therapy
Lead Sponsor:
University Hospital, Geneva
Conditions:
Nightmares, REM-Sleep Type
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
With this protocol, investigators examine whether targeted memory reactivation (TMR), a technique used to strengthen memories, can accelerate remission of nightmare disorder. This protocol uses TMR du...
Eligibility Criteria
Inclusion
- Diagnosis of nightmare disorder according to the International Classification of Sleep Disorders (ICSD-3) diagnostic and coding manual
- Patients with at least moderate severity (\>1 episode per week)
Exclusion
- severe depression
- insomnia disorder
- psychosis or anxiety disorder
- other sleep disorder (e.g.,obstructive sleep apnea syndrome, restless legs syndrome)
- neurological disease
- use of medications that would be likely to produce nightmares (e.g. hypnotics, β-blockers, amphetamines, antimicrobial agents)
- use of anxiolytics, antipsychotic or antidepressant medication were excluded.
Key Trial Info
Start Date :
February 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT05237778
Start Date
February 1 2020
End Date
January 31 2022
Last Update
February 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Sleep Medicine, University Hospitals of Geneva
Geneva, Switzerland, 1225